LobbyingKolon Tissuegene lobbying by quarter
Kolon Tissuegene's latest lobbying report covers Q4 2024, at $50K. Its first report covers Q1 2024; the issues it reports most are Aerospace and Health Issues.
Kolon Tissuegene
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2024 | $80K | 1 |
| Q2 2024 | $80K | 1 |
| Q3 2024 | $80K | 1 |
| Q4 2024 | $50K | 1 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Aerospace$145K · 4 reports
- Health issues$145K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Commerce, Dept of (DOC)4 reports
- Defense Advanced Research Projects Agency (DARPA)4 reports
- Defense, Dept of (DOD)4 reports
- Health & Human Services, Dept of (HHS)4 reports
- HOUSE OF REPRESENTATIVES4 reports
- Natl Aeronautics & Space Administration (NASA)4 reports
- Natl Institutes of Health (NIH)4 reports
- SENATE4 reports
- Veterans Affairs, Dept of (VA)4 reports
- State, Dept of (DOS)2 reports
- U.S. Trade Representative (USTR)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| The Livingston Group | $290K | 4 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/01/21for Q3 2024 | The Livingston Group | $80K |
| 25/01/21for Q4 2024 | The Livingston Group | $50K |
| 24/10/16for Q3 2024 | The Livingston Group | $80K |
| 24/07/15for Q2 2024 | The Livingston Group | $80K |
| 24/04/15for Q1 2024 | The Livingston Group | $80K |
| 24/01/31for Q1 2024 | The Livingston Group | Under $5,000 |